132 related articles for article (PubMed ID: 1647795)
1. Na+, K(+)-ATPase inhibition and intracellular electrolyte content in essential and secondary hypertension.
Spieker C; Zidek W; Rahn KH
Am J Hypertens; 1991 Apr; 4(4 Pt 1):309-14. PubMed ID: 1647795
[TBL] [Abstract][Full Text] [Related]
2. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade.
Kramer HJ; Glänzer K; Freitag T; Schönfeld J; Sorger M; Schlebusch H; Düsing R; Krück F
Klin Wochenschr; 1985 Jan; 63(1):32-6. PubMed ID: 2579261
[TBL] [Abstract][Full Text] [Related]
3. A circulating Na+-K+ATPase inhibitor, erythrocyte sodium transport and hypertension in patients with chronic renal failure.
Kariya K; Sano H; Yamanishi J; Saito K; Furuta Y; Fukuzaki H
Clin Exp Hypertens A; 1986; 8(2):167-83. PubMed ID: 2424645
[TBL] [Abstract][Full Text] [Related]
4. (Na+ + K+) ATPase inhibitors and intracellular electrolytes in essential hypertension.
Iwaoka T; Nugent CA; Umeda T; Sato T
Jpn Heart J; 1987 Sep; 28(5):695-705. PubMed ID: 2828706
[TBL] [Abstract][Full Text] [Related]
5. Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.
Shahid SM; Mahboob T
Pak J Pharm Sci; 2008 Apr; 21(2):172-9. PubMed ID: 18390448
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte sodium and Na+, K(+)-ATPase activity in untreated hypertensives and their first degree relatives.
Sudhakar K; Sujatha M; Devi CV; Reddy PP
Indian J Biochem Biophys; 1998 Dec; 35(6):382-4. PubMed ID: 10412234
[TBL] [Abstract][Full Text] [Related]
7. Plasma Na+-K+ ATPase inhibitory activity in normal and hypertensive subjects: relationship to intracellular electrolytes and blood pressure.
Boschi S; Borghi C; Costa FV; Ambrosioni E
Clin Exp Hypertens A; 1985; 7(5-6):735-53. PubMed ID: 2990769
[TBL] [Abstract][Full Text] [Related]
8. Ca2+i:K+i ratio and total intracellular calcium in essential and renal hypertension.
Zidek W; Spieker C; Vetter H
J Hypertens; 1986 Aug; 4(4):507-10. PubMed ID: 3772102
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a Na-K-ATPase-inhibitor in erythrocytes of patients with essential hypertension.
Walter U; Müller S
Eur J Clin Invest; 1985 Aug; 15(4):209-14. PubMed ID: 2995050
[TBL] [Abstract][Full Text] [Related]
10. Na-K-adenosine triphosphatase and cation content in the erythrocyte in essential hypertension.
Rahman M; Koh H; Primera MI; Del Greco F; Quintanilla AP
J Lab Clin Med; 1986 Apr; 107(4):337-41. PubMed ID: 3007645
[TBL] [Abstract][Full Text] [Related]
11. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
[TBL] [Abstract][Full Text] [Related]
12. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
[TBL] [Abstract][Full Text] [Related]
13. [Alcohol-related high blood pressure, and erythrocyte Na+/K(+)-ATPase activity, sodium and potassium concentrations].
Tsuritani I; Teraoka K; Miyagoshi M; Honda R; Ishizaki M; Yamada Y
Rinsho Byori; 1993 Dec; 41(12):1353-7. PubMed ID: 8295347
[TBL] [Abstract][Full Text] [Related]
14. Intracellular calcium in secondary hypertension.
Spieker C; Zidek W; Vetter H; Losse H
Nephron; 1987; 47 Suppl 1():146-8. PubMed ID: 2447514
[TBL] [Abstract][Full Text] [Related]
15. Copper modifies the activity of sodium-transporting systems in erythrocyte membrane in patients with essential hypertension.
Kedzierska K; Bober J; Ciechanowski K; Gołembiewska E; Kwiatkowska E; Noceń I; Dołegowska B; Dutkiewicz G; Chlubek D
Biol Trace Elem Res; 2005 Oct; 107(1):21-32. PubMed ID: 16170219
[TBL] [Abstract][Full Text] [Related]
16. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
Maslova MN; Ogorodnikova LE; Titkov IuS
Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic factor modulates the plasma levels of a Na+/K+ATPase inhibitor in volume expanded borderline hypertensives.
Borghi C; Boschi S; Costa FV; Ambrosioni E
Am J Hypertens; 1991 Jul; 4(7 Pt 1):618-22. PubMed ID: 1651740
[TBL] [Abstract][Full Text] [Related]
18. Abnormal red cell sodium content and efflux in Japanese patients with essential hypertension.
Saito K; Furuta Y; Fukuzaki H
Jpn Circ J; 1984 Sep; 48(9):980-7. PubMed ID: 6090719
[TBL] [Abstract][Full Text] [Related]
19. Ionic and allied variations in normotensive and hypertensive diabetic patients.
Shahid SM; Jawed M; Mahboob T
J Pak Med Assoc; 2005 Apr; 55(4):153-8. PubMed ID: 15918627
[TBL] [Abstract][Full Text] [Related]
20. [Various properties of the Na+, K(+)-ATPase and the Mg (2+)-ATPase in erythrocytes from normotensive and hypertensive subjects].
Canestrari F; Galli F; Gheller G; De Crescentini S; Biagiarelli B
Boll Soc Ital Biol Sper; 1991 Jul; 67(7):659-66. PubMed ID: 1667978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
